Literature DB >> 33498085

Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.

Hannah M Stephen1, Trevor M Adams1, Lance Wells1.   

Abstract

Thousands of nuclear and cytosolic proteins are modified with a single β-N-acetylglucosamine on serine and threonine residues in mammals, a modification termed O-GlcNAc. This modification is essential for normal development and plays important roles in virtually all intracellular processes. Additionally, O-GlcNAc is involved in many disease states, including cancer, diabetes, and X-linked intellectual disability. Given the myriad of functions of the O-GlcNAc modification, it is therefore somewhat surprising that O-GlcNAc cycling is mediated by only two enzymes: the O-GlcNAc transferase (OGT), which adds O-GlcNAc, and the O-GlcNAcase (OGA), which removes it. A significant outstanding question in the O-GlcNAc field is how do only two enzymes mediate such an abundant and dynamic modification. In this review, we explore the current understanding of mechanisms for substrate selection for the O-GlcNAc cycling enzymes. These mechanisms include direct substrate interaction with specific domains of OGT or OGA, selection of interactors via partner proteins, posttranslational modification of OGT or OGA, nutrient sensing, and localization alteration. Altogether, current research paints a picture of an exquisitely regulated and complex system by which OGT and OGA select substrates. We also make recommendations for future work, toward the goal of identifying interaction mechanisms for specific substrates that may be able to be exploited for various research and medical treatment goals.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  O-GlcNAc; OGA; OGT; substrate selection

Mesh:

Substances:

Year:  2021        PMID: 33498085      PMCID: PMC8351506          DOI: 10.1093/glycob/cwab005

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  6 in total

Review 1.  O-GlcNAcylation regulation of cellular signaling in cancer.

Authors:  Lorela Ciraku; Emily M Esquea; Mauricio J Reginato
Journal:  Cell Signal       Date:  2021-11-17       Impact factor: 4.315

2.  Regulation of the urea cycle by CPS1 O-GlcNAcylation in response to dietary restriction and aging.

Authors:  Jing Wu; Jiayu Liu; Kalina Lapenta; Reina Desrouleaux; Min-Dian Li; Xiaoyong Yang
Journal:  J Mol Cell Biol       Date:  2022-07-05       Impact factor: 8.185

Review 3.  The Beginner's Guide to O-GlcNAc: From Nutrient Sensitive Pathway Regulation to Its Impact on the Immune System.

Authors:  Michael P Mannino; Gerald W Hart
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

4.  NAT10 Maintains OGA mRNA Stability Through ac4C Modification in Regulating Oocyte Maturation.

Authors:  Jiayu Lin; Yuting Xiang; Jiana Huang; Haitao Zeng; Yanyan Zeng; Jiawen Liu; Taibao Wu; Qiqi Liang; Xiaoyan Liang; Jingjie Li; Chuanchuan Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

5.  Ventromedial hypothalamic OGT drives adipose tissue lipolysis and curbs obesity.

Authors:  Qi Wang; Bichen Zhang; Bernardo Stutz; Zhong-Wu Liu; Tamas L Horvath; Xiaoyong Yang
Journal:  Sci Adv       Date:  2022-08-31       Impact factor: 14.957

6.  Tripeptide Leu-Pro-Phe from Corn Protein Hydrolysates Attenuates Hyperglycemia-Induced Neural Tube Defect in Chicken Embryos.

Authors:  Chang-Yu Yan; Jie Sun; Gui-Yuan Yu; Jiang-Han-Zi Liu; Rong-Ping Huang; Shao-Cong Han; Qiong-Yi Zhang; Xiao-Min Li; Jian-Gang Yan; Hiroshi Kurihara; Wei-Xi Li; Yi-Fang Li; Rong-Rong He
Journal:  Oxid Med Cell Longev       Date:  2022-08-29       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.